![Scientist measures samples in a lab](https://images.prismic.io/baker-tilly-www%2F095fef8e-d480-4116-b12b-b522946180ac_life-sciences.jpg?auto=compress,format&rect=251,0,4992,3744&w=20&h=15)
Healthcare payers want more information about new pharma products’ outcomes sooner than ever. Baker Tilly’s Darren Jones talks with PM360 Magazine about how pharmaceutical companies should make a long-term commitment to measuring outcomes as early as possible to provide the real-world evidence payers are seeking and drive commercial success.